Medical devices, healthcare technology and the business of care
510(k) clearance · K260023

TumorSight Risk

SimBioSys, Inc. · Decision date Sep 25, 2026

MEDTECHLEDGER EXPLANATIONK260023

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for TumorSight Risk, submitted by SimBioSys, Inc., under 510(k) number K260023, with a decision date of September 25, 2026 and a receipt date of January 5, 2026. The device is a Class II software algorithm device analyzing digital images for cancer prognosis, regulation 21 CFR 864.3755, product code SHW, in the pathology specialty. The summary names ArteraAI Breast (K254115) as the legally marketed predicate. SESE means clearance, not PMA approval.

Per the indications for use, TumorSight Risk is a software-only device that combines age, race, cancer stage, nodal status and grade with DCE-MRI data to produce 5- and 10-year recurrence risks and a proprietary score, intended for adult women with HR+/HER2- Stage I-IIIA breast cancer. Its multi-tissue segmentation input is a validated output of TumorSight Viz (K251766). The record does not include the clinical validation results, performance metrics or the basis for the equivalence determination; those would need review of the linked decision summary.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Pathology
Decision date
Sep 25, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260023
Regulatory pathway
510(k) premarket notification
Product code
SHW
Decision code
SESE
Decision date
Sep 25, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Pathology Software Algorithm Device Analyzing Digital Images For Breast Cancer Prognosis.

Product code
SHW
FDA device class
2

FDA decision timeline

  1. K260023 received

    Application receipt date recorded by FDA.

  2. K260023 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

SimBioSys, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Chicago, IL

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records